Literature DB >> 18544192

Worldwide burden of COPD in high- and low-income countries. Part II. Burden of chronic obstructive lung disease in Latin America: the PLATINO study.

A M B Menezes1, R Perez-Padilla, P C Hallal, J R Jardim, A Muiño, M V Lopez, G Valdivia, J Pertuze, M Montes de Oca, C Tálamo.   

Abstract

SETTING: Five Latin American cities: São Paulo, Brazil; Mexico City, Mexico; Montevideo, Uruguay; Santiago, Chile; Caracas, Venezuela.
OBJECTIVE: To describe the burden of chronic obstructive pulmonary disease (COPD) in Latin America.
DESIGN: This is a multicentre study. Post-bronchodilator spirometry was used and the main outcome measure was FEV(1)/FVC < 0.7 (fixed ratio criterion). Global Obstructive Lung Disease (GOLD) stages were also analysed.
RESULTS: The combined population aged > or =40 years in the five countries included in the study was approximately 85.3 million. Of these, it was estimated that 12.2 million have airflow obstruction, which corresponds to our prevalence estimate of 14.3%. The proportion of subjects in Stages II-IV of the GOLD classification was 5.6%. Risk factors presenting the highest aetiological fractions for COPD were age, current smoking, indoor exposure to coal and exposure to dust in the workplace. Smoking, the modifiable factor with the strongest aetiological fraction for COPD, affects 29.2% of adults aged > or =40 years in these cities, corresponding to approximately 25 million smokers in this age group.
CONCLUSION: Prevention of smoking and exposure to pollutants, such as coal and dust, are the interventions most likely to succeed against COPD in Latin America. The information obtained by a collaborative study has been vast and encouraging for other similar studies.

Entities:  

Mesh:

Year:  2008        PMID: 18544192

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  12 in total

1.  Greater Access to Long Acting Beta2 Agonists Is Associated with Less Hospital Admissions Due to COPD: A Longitudinal Nation-Wide Study.

Authors:  Eduardo Vieira Ponte; Álvaro A Cruz; Valmar Bião Lima; Rafael Stelmach; Giovanni Viegi
Journal:  Lung       Date:  2018-09-05       Impact factor: 2.584

Review 2.  Epidemiology and management of common pulmonary diseases in older persons.

Authors:  Kathleen M Akgün; Kristina Crothers; Margaret Pisani
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-02-15       Impact factor: 6.053

Review 3.  Role of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary disease.

Authors:  Paul W Jones; David Price; Thys van der Molen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-05-26

4.  Teenage smoking behaviour following a high-school smoking ban in Chile: interrupted time-series analysis.

Authors:  Andrea B Feigl; Joshua A Salomon; Goodarz Danaei; Eric L Ding; Esteban Calvo
Journal:  Bull World Health Organ       Date:  2015-04-29       Impact factor: 9.408

Review 5.  Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 century.

Authors:  Rafael Laniado-Laborín
Journal:  Int J Environ Res Public Health       Date:  2009-01-09       Impact factor: 3.390

6.  Primary care physician perceptions on the diagnosis and management of chronic obstructive pulmonary disease in diverse regions of the world.

Authors:  Zaurbek Aisanov; Chunxue Bai; Otto Bauerle; Federico D Colodenco; Charles Feldman; Shu Hashimoto; Jose Jardim; Christopher K W Lai; Rafael Laniado-Laborin; Gilbert Nadeau; Abdullah Sayiner; Jae Jeong Shim; Ying Huang Tsai; Richard D Walters; Grant Waterer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-04-05

7.  Risk factors for pulmonary tuberculosis in patients with chronic obstructive airway disease in Taiwan: a nationwide cohort study.

Authors:  Chih-Hsin Lee; Ming-Chia Lee; Chin-Chung Shu; Chor-Shen Lim; Jann-Yuan Wang; Li-Na Lee; Kun-Mao Chao
Journal:  BMC Infect Dis       Date:  2013-04-30       Impact factor: 3.090

Review 8.  Chronic obstructive pulmonary disease.

Authors:  V K Vijayan
Journal:  Indian J Med Res       Date:  2013-02       Impact factor: 2.375

9.  Diagnosis of COPD and clinical course in patients with unrecognized airflow limitation.

Authors:  Daniel E Murphy; Ralph J Panos
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-04-18

10.  Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010.

Authors:  Timothy Tilert; Charles Dillon; Ryne Paulose-Ram; Eva Hnizdo; Brent Doney
Journal:  Respir Res       Date:  2013-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.